Regression analyses and assessments of predictive power were adjusted for key variables, including maximum cardiac biomarker levels, sex, age, infarction type, time from symptom onset to admission, infarct-related vessel, and high-sensitivity C-reactive protein (hs-CRP). This evidence concerns the gene CRP and infarction.